The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ immunotherapy, Libtayo, as an add-on ...
2don MSN
Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug
Zenas BioPharma said on Wednesday it has secured global rights to develop and commercialize an experimental drug from China-based InnoCare Pharma for multiple sclerosis and other autoimmune conditions ...
Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.
The opening night of the Jonas Brothers’ JONAS20: Greetings From Your Hometown Tour was full of surprises, and fans are hoping for plenty more where that came from. The surprises continued on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback